Article
ctDNA as a cancer biomarker: A broad overview.
Critical reviews in oncology/hematology - 1 Nov 2020
Pessoa Luciana Santos, Heringer Manoela, Ferrer Valéria Pereira
Abstract excerpt
Circulating tumor DNA (ctDNA) in fluids has gained attention because ctDNA seems to identify tumor-specific abnormalities, which could be used for diagnosis, follow-up of treatment, and prognosis: the so-called liquid biopsy. Liquid biopsy is a minimally invasive approach and presents the sum of ctDNA from primary and secondary tumor sites. It has been possible not only to quantify the amount of ctDNA but also to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
